会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 31. 发明申请
    • METHODS FOR THE MODULATION OF NEOVASCULARIZATION AND/OR THE GROWTH OF COLLATERAL ARTERIES AND/OR OTHER ARTERIES FROM PREEXISTING ARTERIOLAR CONNECTIONS
    • 调查近期和/或殖民地和/或其他风险的增长的方法来自预防性干扰素连接
    • US20090191146A1
    • 2009-07-30
    • US12332937
    • 2008-12-11
    • IVO R. BUSCHMANNWolfgang Schaper
    • IVO R. BUSCHMANNWolfgang Schaper
    • A61K38/00A61P9/00
    • A61K38/193A61K48/00
    • Described is the modulation of the neovascularization and/or growth of collateral arteries and/or other arteries from preexisting arteriolar connections. Methods are provided for enhancing neovascularization and/or the growth of collateral arteries and/or other arteries from preexisting arteriolar connections comprising contacting organs, tissue or cells with a colony stimulating factor (CSF) or a nucleic acid molecule encoding said CSF. Furthermore, the use of a CSF or a nucleic acid molecule encoding said CSF for the preparation of pharmaceutical compositions for enhancing neovascularization and/or collateral growth of collateral arteries and/or other arteries from preexisting arteriolar connections is described. Also provided are methods for the treatment of tumors comprising contacting an organ, tissue or cells with an agent which suppresses neovascularization and/or the growth of collateral arteries and/or other arteries from preexisting arteriolar connections through the inhibition of the biological activity of CSFs. Described is further the use of an agent which suppresses neovascularization and/or the growth of collateral arteries and/or other arteries from preexisting arteriolar connections through inhibition of the biological activity of CSFs for the preparation of pharmaceutical compositions for the treatment of tumors.
    • 描述了来自预先存在的小动脉连接的侧支动脉和/或其他动脉的新生血管形成和/或生长的调节。 提供了用于增强来自预先存在的小动脉连接的侧支动脉和/或其它动脉的新生血管形成和/或生长的方法,包括使器官,组织或细胞与集落刺激因子(CSF)或编码所述CSF的核酸分子接触。 此外,描述了编码所述CSF用于制备用于增强来自预先存在的小动脉连接的侧支动脉和/或其他动脉的新生血管形成和/或侧支生长的药物组合物的CSF或核酸分子的用途。 还提供了用于治疗肿瘤的方法,包括通过抑制CSF的生物学活性使器官,组织或细胞与抑制新生血管形成和/或副前动脉和/或其它动脉从预先存在的小动脉连接生长的药剂接触。 还描述了通过抑制用于制备用于治疗肿瘤的药物组合物的CSF的生物活性来抑制来自预先存在的小动脉连接的侧支动脉和/或其它动脉的新生血管形成和/或生长的药剂的用途。
    • 36. 发明授权
    • Methods for the modulation of neovascularization and/or the growth of collateral arteries and/or other arteries from preexisting arteriolar connections
    • 调节新生血管形成和/或来自预先存在的小动脉连接的侧支动脉和/或其他动脉生长的方法
    • US07507705B2
    • 2009-03-24
    • US09509764
    • 1998-10-01
    • Ivo R. BuschmannWolfgang Schaper
    • Ivo R. BuschmannWolfgang Schaper
    • A61K38/00A01N37/18A61K31/70A01N43/04
    • A61K38/193A61K48/00
    • Described is the modulation of the neovascularization and/or growth of collateral arteries and/or other arteries from preexisting arteriolar connections. Methods are provided for enhancing neovascularization and/or the growth of collateral arteries and/or other arteries from preexisting arteriolar connections comprising contacting organs, tissue or cells with a colony stimulating factor (CSF) or a nucleic acid molecule encoding a CSF. Furthermore, the use of a CSF or a nucleic acid molecule encoding a CSF for the preparation of pharmaceutical compositions for enhancing neovascularization and/or collateral growth of collateral arteries and/or other arteries from preexisting arteriolar connections is described. Also provided are methods for the treatment of tumors comprising contacting an organ, tissue or cells with an agent which suppresses neovascularization and/or the growth of collateral arteries and/or other arteries from preexisting arteriolar connections through the inhibition of the biological activity of CSFs. Described is further the use of an agent which suppresses neovascularization and/or the growth of collateral arteries and/or other arteries from preexisting arteriolar connections through inhibition of the biological activity of CSFs for the preparation of pharmaceutical compositions for the treatment of tumors.
    • 描述了来自预先存在的小动脉连接的侧支动脉和/或其他动脉的新生血管形成和/或生长的调节。 提供了用于增强来自预先存在的小动脉连接的侧支动脉和/或其他动脉的新生血管形成和/或生长的方法,其包括使器官,组织或细胞与集落刺激因子(CSF)或编码CSF的核酸分子接触。 此外,描述了使用CSF或编码CSF的核酸分子来制备用于增强来自预先存在的小动脉连接的侧支动脉和/或其他动脉的新生血管形成和/或侧支生长的药物组合物。 还提供了用于治疗肿瘤的方法,包括通过抑制CSF的生物学活性使器官,组织或细胞与抑制新生血管形成和/或副前动脉和/或其它动脉从预先存在的小动脉连接生长的药剂接触。 还描述了通过抑制用于制备用于治疗肿瘤的药物组合物的CSF的生物活性来抑制来自预先存在的小动脉连接的侧支动脉和/或其它动脉的新生血管形成和/或生长的药剂的用途。
    • 38. 发明授权
    • Methods for the modulation of the growth of collateral arteries and/or other arteries from preexisting arteriolar connections
    • 用于调节来自预先存在的小动脉连接的侧支动脉和/或其他动脉生长的方法
    • US06592862B1
    • 2003-07-15
    • US09402358
    • 1999-12-10
    • Wolfgang SchaperWulf D. Ito
    • Wolfgang SchaperWulf D. Ito
    • A61K3819
    • A61K38/1793A61K38/195A61K48/00
    • Described is the modulation of the growth of collateral arteries and/or other arteries from preexisting arterlolar connections. Methods are provided for enhancing the growth of collateral arteries and/or other arteries from preexisting arteriolar connections comprising contacting tissue or cells with a monocyte chemotactic protein (MCP) or a nudeic acid molecule encoding said MCP. Furthermore, the use of a MCP or a nucleic acid molecule encoding said MCP for the preparation of pharmaceutical compositions for enhancing collateral growth of collateral arteries and/or other arteries from preexisting arteriolar connections is described, Also provided are methods for the treatment of tumors comprising contacting tissue or cells with an agent which suppresses the growth of collateral arteries and/or other arteries from preexisting arteriolar connections through the attraction of monocytes. Described is further the use of an agent which suppresses the growth of collateral arteries and/or other arteries from preexisting arteriolar connections through attraction of monocytes for the preparation of pharmaceutical compositions for the treatment of tumors.
    • 描述了来自预先存在的动脉关节连接的侧支动脉和/或其他动脉的生长的调节。 提供了用于增强来自预先存在的小动脉连接的侧支动脉和/或其他动脉的生长的方法,其包括使组织或细胞与编码所述MCP的单核细胞趋化蛋白(MCP)或裸露酸分子接触。 此外,还描述了使用MCP或编码所述MCP的核酸分子来制备用于增强来自预先存在的小动脉连接的侧支动脉和/或其他动脉的侧支生长的药物组合物,还提供了治疗肿瘤的方法,包括 使组织或细胞与通过单核细胞的吸引抑制来自预先存在的小动脉连接的侧支动脉和/或其它动脉的生长的药剂接触。 还描述了通过吸引单核细胞来制备用于治疗肿瘤的药物组合物来抑制来自预先存在的小动脉连接的侧支动脉和/或其它动脉生长的药剂的用途。